SHANDONG BAILONG CHUANGYUAN BIO-TECH CO.,LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 605016 for the last quarter is 214.47 M CNY, and it's 10.27% lower compared to the previous quarter. The net income of Q4 23 is 51.65 M CNY.